期刊文献+

基于质谱的DNA加合物组技术在药学领域应用的研究进展 被引量:1

Research progress in application of mass spectrometry-based DNA adduct technology in field of pharmacy
原文传递
导出
摘要 DNA加合物是评价DNA损伤最直接的分子证据,随之产生一个专门研究DNA修饰识别和DNA加合物定量的新领域——DNA加合物组学。其中质谱(MS)分析法是常用的DNA加合物组学技术,并且随着质谱分析仪的灵敏度和扫描速度的提高,使得利用DNA加合物组学技术来筛查人类基因组中DNA损伤成为可能。其中,基于质谱技术对马兜铃、巴豆醛等致癌物生成的DNA加合物的种类的检测应用十分广泛。主要就基于质谱的加合物组学检测技术及其在致癌物检测中的应用进行概述。 DNA adducts are the most direct molecular evidence for evaluating DNA damage,and a new field specializing in DNA modification recognition and DNA adduct quantification—DNA adductomics has emerged.Mass spectrometry(MS)is a commonly used DNA adductomics technology,and with the increase in the sensitivity and scanning speed of mass spectrometry,the use of DNA adductomics technology to screen DNA in the human genome Damage becomes possible.The detection of DNA adducts produced by carcinogens such as aristolochia and crotonaldehyde based on mass spectrometry is very widely used.This article mainly summarizes the adductomics detection technology based on mass spectrometry and its application in the detection of carcinogens.
作者 闫明 叶倩 王雪 文海若 YAN Ming;YE Qian;WANG Xue;WEN Hairuo(China Pharmaceutical University,Nanjing 211198,China;National Center for Safety Evaluation of Drugs,National Institutes for Food and Drug Control,Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs,Beijing 100176,China)
出处 《药物评价研究》 CAS 2021年第4期876-884,共9页 Drug Evaluation Research
基金 国家“重大新药创制”科技重大专项(2018ZX09201017-001) 中国食品药品检定研究院学科带头人培养基金资助项目(2019X4)。
关键词 DNA加合物 加合物组学 质谱 致癌物 DNA adduct DNA adductomics MS carcinogens
  • 相关文献

参考文献4

二级参考文献33

  • 1王美娥,周启星.DNA加合物的形成、诊断与污染暴露指示研究进展[J].应用生态学报,2004,15(10):1983-1987. 被引量:6
  • 2Stiborova M, Frei E, Hodek P, et al. Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH: Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer [ J ]. Int J Cancer, 2005, 113(2) : 189 - 197.
  • 3Mei N, Arh VM, Phillips DH, et al. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver[J]. Mutat Res-Fund Mol M, 2006, 602:83 -91.
  • 4Feldmeyer N, Schmeiser HH, Muehlbauer KR, et al. Further studies with a cell immortalization assay to investigate the mutation signature Of arlstolochic acid in human P53 sequenees[J]. Murat Res, 2006, 608:163-168.
  • 5Singh R, Farmer PB. Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection[J]. Carcinogenesis, 2006, 27(2) : 178 - 196.
  • 6Beland FA, Churchwell MI, Doerge DR, et al. Electrospray ionization-tandem mass spectrometry and ^32P-postlabeling analyses of tamoxifen-DNA adducts in humans [ J ]. J Natl Cancer Inst, 2004, 96 (14) : 1099-1104.
  • 7Stiborova M, Sopko B, Hodek P, et al. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen [ J ]. Cancer Lett, 2005, 229 : 193 - 204.
  • 8Arlt VM, Alunni-Perret V, Quatrehomme G, et al. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer [J]. Int J Cancer, 2004, 111 : 977 - 980.
  • 9Rodgman A. Problems with the Tobacco Products Scientific Advisory Committee (TPSAC) list of harmful or potentially harmful tobacco and/or tobacco smoke components [ J ]. Beitrige zur Tabakforschung International, 2011,24 ( 6 ) .. 258-276.
  • 10Chen P, Moldoveanu S. Mainstream smoke chemicalanalyses for 2R4F Kentucky reference cigarette [J]. Beitrige zur Tabakforschung International, 2003, 20 (7) : 448-458.

共引文献7

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部